BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26738505)

  • 1. Can prostatic arterial embolisation (PAE) reduce the volume of the peripheral zone? MRI evaluation of zonal anatomy and infarction after PAE.
    Lin YT; Amouyal G; Correas JM; Pereira H; Pellerin O; Del Giudice C; Déan C; Thiounn N; Sapoval M
    Eur Radiol; 2016 Oct; 26(10):3466-73. PubMed ID: 26738505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphometric analysis of prostate zonal anatomy using magnetic resonance imaging: impact on age-related changes in patients in Japan and the USA.
    Matsugasumi T; Fujihara A; Ushijima S; Kanazawa M; Yamada Y; Shiraishi T; Hongo F; Kamoi K; Okihara K; de Castro Abreu AL; Oishi M; Shin T; Palmer S; Gill IS; Ukimura O
    BJU Int; 2017 Oct; 120(4):497-504. PubMed ID: 28220583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenomatous-Dominant Benign Prostatic Hyperplasia (AdBPH) as a Predictor for Clinical Success Following Prostate Artery Embolization: An Age-Matched Case-Control Study.
    Little MW; Boardman P; Macdonald AC; Taylor N; Macpherson R; Crew J; Tapping CR
    Cardiovasc Intervent Radiol; 2017 May; 40(5):682-689. PubMed ID: 28194505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI features after prostatic artery embolization for the treatment of medium- and large-volume benign hyperplasia.
    Zhang H; Shen Y; Pan J; Wang H; Zhong Y; Wang Y; Ye H
    Radiol Med; 2018 Oct; 123(10):727-734. PubMed ID: 29752646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign prostatic hyperplasia after prostatic arterial embolization in a canine model: A 3T multiparametric MRI and whole-mount step-section pathology correlated longitudinal study.
    Li B; Xu A; Wang N; Min X; Feng Z; Deng M; Li L; Cai J; Kang Z; Jiang K; Kuang D; Wang L
    J Magn Reson Imaging; 2017 Oct; 46(4):1220-1229. PubMed ID: 28182304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients.
    Turkbey B; Huang R; Vourganti S; Trivedi H; Bernardo M; Yan P; Benjamin C; Pinto PA; Choyke PL
    BJU Int; 2012 Dec; 110(11):1642-7. PubMed ID: 22973825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate Zonal Volumetry as a Predictor of Clinical Outcomes for Prostate Artery Embolization.
    de Assis AM; Maciel MS; Moreira AM; de Paula Rodrigues VC; Antunes AA; Srougi M; Cerri GG; Carnevale FC
    Cardiovasc Intervent Radiol; 2017 Feb; 40(2):245-251. PubMed ID: 27872986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of contrast-enhanced ultrasonography in detection of prostatic infarction after prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia.
    Moschouris H; Stamatiou K; Malagari K; Marmaridou K; Kladis-Kalentzis K; Kiltenis M; Papadogeorgopoulos N; Tsavari A; Manoloudaki K
    Diagn Interv Radiol; 2019 Mar; 25(2):134-143. PubMed ID: 30860077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR imaging findings of the prostate gland following prostate artery embolization: results from a prospective phase 2 study.
    Ali R; Gabr A; Mouli SK; Kallini JR; Riaz A; Mora R; Lewandowski RJ; Hohlastos E; Casalino DD; Hofer MD; Hamoui N; Miller FH; Hairston J; Salem R
    Abdom Radiol (NY); 2019 Feb; 44(2):713-722. PubMed ID: 30196364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate artery embolisation: an all-comers, single-operator experience in 159 patients with lower urinary tract symptoms, urinary retention, or haematuria with medium-term follow-up.
    Thulasidasan N; Kok HK; Elhage O; Clovis S; Popert R; Sabharwal T
    Clin Radiol; 2019 Jul; 74(7):569.e1-569.e8. PubMed ID: 30955835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI assessment of prostatic ischaemia: best predictor of clinical success after prostatic artery embolisation for benign prostatic hyperplasia.
    Kisilevzky N; Faintuch S
    Clin Radiol; 2016 Sep; 71(9):876-82. PubMed ID: 27296474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast enhanced ultrasound (CEUS) with parametric imaging and time intensity curve analysis (TIC) for evaluation of the success of prostate arterial embolization (PAE) in cases of prostate hyperplasia.
    Jung EM; Wertheimer T; Putz FJ; Jung F; Kammerer S; Pregler B; Luerken L; Stroszczynski C; Beyer L
    Clin Hemorheol Microcirc; 2020; 76(2):143-153. PubMed ID: 32925006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-vesical Prostatic Protrusion (IPP) Can Be Reduced by Prostatic Artery Embolization.
    Lin YT; Amouyal G; Thiounn N; Pellerin O; Pereira H; Del Giudice C; Déan C; Sapoval M
    Cardiovasc Intervent Radiol; 2016 May; 39(5):690-695. PubMed ID: 26542027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The STREAM Trial (Prostatic Artery Embolization for the Treatment of Benign Prostatic Hyperplasia) 24-Month Clinical and Radiological Outcomes.
    Tapping CR; Little MW; Macdonald A; Mackinnon T; Kearns D; Macpherson R; Crew J; Boardman P
    Cardiovasc Intervent Radiol; 2021 Mar; 44(3):436-442. PubMed ID: 33210152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates.
    Wang M; Guo L; Duan F; Yuan K; Zhang G; Li K; Yan J; Wang Y; Kang H
    BJU Int; 2016 Jan; 117(1):155-64. PubMed ID: 25851432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption Study.
    Salem R; Hairston J; Hohlastos E; Riaz A; Kallini J; Gabr A; Ali R; Jenkins K; Karp J; Desai K; Thornburg B; Casalino D; Miller F; Hofer M; Hamoui N; Mouli S
    Urology; 2018 Oct; 120():205-210. PubMed ID: 30036614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Clinical Outcome after Prostate Artery Embolization with Spherical and Nonspherical Polyvinyl Alcohol Particles in Patients with Benign Prostatic Hyperplasia.
    Bilhim T; Pisco J; Pereira JA; Costa NV; Fernandes L; Campos Pinheiro L; Duarte M; Oliveira AG
    Radiology; 2016 Oct; 281(1):289-300. PubMed ID: 27223621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostatic Arterial Embolization Followed by Holmium Laser Enucleation of the Prostate as a Planned Combined Approach for Extremely Enlarged Benign Prostate Hyperplasia.
    Li P; Wang C; Cao Q; Zhang J; Shi H; Meng X
    Urol Int; 2017; 99(4):422-428. PubMed ID: 28768261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic Arterial Embolization with Small Sized Particles for the Treatment of Lower Urinary Tract Symptoms Due to Large Benign Prostatic Hyperplasia: Preliminary Results.
    Li Q; Duan F; Wang MQ; Zhang GD; Yuan K
    Chin Med J (Engl); 2015 Aug; 128(15):2072-7. PubMed ID: 26228221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between prostate size and glandular tissue volume of the peripheral zone via novel combined MRI and histopathology: possible pathophysiological implications on prostate cancer development.
    Lin B; Cavdar IK; Buxton M; Sellers J; Brandi L; Helo N; de Riese WTW
    Int Urol Nephrol; 2023 Apr; 55(4):835-844. PubMed ID: 36739353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.